Global Organ-on-Chip Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

An organ-on-a-chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-on-a-chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Global Organ-on-Chip key players include Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems, etc. Global top five manufacturers hold a share about 55%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Liver-on-a-chip is the largest segment, with a share about 30%. And in terms of application, the largest application is Pharmaceutical & Biotechnology Companies, followed by Academic & Research Institutes.

Market Analysis and Insights: Global Organ-on-Chip Market
In 2020, the global Organ-on-Chip market size was US$ 41 million and it is expected to reach US$ 423.4 million by the end of 2027, with a CAGR of 39.9% during 2021-2027.
Global Organ-on-Chip Scope and Market Size
Organ-on-Chip market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Organ-on-Chip market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Organ-on-Chip market is segmented into
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Others

Segment by End Users, the Organ-on-Chip market is segmented into
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Cosmetics Industry
Other End Users

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape

and Organ-on-Chip Market Share Analysis
Organ-on-Chip market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Organ-on-Chip product introduction, recent developments, Organ-on-Chip sales by region, type, application and by sales channel.

The major companies include:
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory

Frequently Asked Questions